Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens
- 21 January 2008
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 41 (10) , 887-893
- https://doi.org/10.1038/sj.bmt.1705987
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHDBlood, 2006
- Extending Postgrafting Cyclosporine Decreases the Risk of Severe Graft-versus-Host Disease after Nonmyeloablative Hematopoietic Cell TransplantationTransplantation, 2006
- Risk factors associated with increased grades III-IV acute graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT)Transplantation and Cellular Therapy, 2006
- Graft-vs-host disease after non-myeloablative hematopoietic cell transplantationLeukemia & Lymphoma, 2005
- Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft‐versus‐host diseaseBritish Journal of Haematology, 2005
- Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioningBone Marrow Transplantation, 2004
- Evaluation of Thalidomide for Treatment or Prevention of Chronic Graft-versus-host DiseaseLeukemia & Lymphoma, 2003
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979